Health Policy Weekly Archive

US Capitol building

November 12, 2021

Doesn’t everyone read legislative text cozy near a fire pit? Status of the Build Back Better Act

November 5, 2021

Just when I thought I was out, they pull me back in: Drug pricing provisions

October 29, 2021

Abra cadabra. Lobbyists make drug pricing proposals disappear

October 22, 2021

CMMI: Strategic approach more sophisticated than throwing spaghetti at a wall

October 15, 2021

Stars in eyes as open enrollment starts

October 8, 2021

Not quite D-feet but clock ticking

October 1, 2021

Like everyone, our best guess uses fortune paper origami. Yes, no, maybe for Congress to pass a multi-trillion dollar reconciliation bill

September 24, 2021

Foot off the gas: Stalling expedited pathway to coverage

September 17, 2021

If the devil is in the details, this plan is an angel: Administration releases drug pricing proposals

August 27, 2021

A quick update and original research before we take an end-of-summer break

August 20, 2021

It’s like when you hear Déjà vu on the radio for the 20th time minus the strawberry ice cream. Drug pricing reform

August 6, 2021

Bats rely on insects and nectar; hospitals rely on IPPS payment increases

July 30, 2021

Time to discus: FDA approves first interchangeable

July 23, 2021

OPPS, ASC me again? I was distracted with Olympics coverage

July 16, 2021

Anything is popsicle this summer. EO includes drug pricing and importation

July 2, 2021

You can almost feel the finger wag: Biden pushes ahead on ACA changes

June 25, 2021

Writing with a dull pencil is pointless: New drug pricing principles

June 18, 2021

Did Miss Cleo predict this one? ACA upheld

June 11, 2021

Is the FDA advisory committee a potted plant?

June 4, 2021

President Biden’s budget proposal for FY 2022 is “DOA”

May 21, 2021

PIVOT: HRSA responds to contract pharmacy arrangements under 340B

May 14, 2021

It's a light week in health policy news

May 7, 2021

A peony saved is a peony earned. March has lions and lambs, April has showers, May brings drug pricing talks

April 30, 2021

Baby, one more time: Third stimulus package

April 23, 2021

Who run the world? Girls. HHS nomination update

April 16, 2021

Like the trees, re-leafed about nomination hearing

April 9, 2021

In anticipation of some special sauce, (Big) MAC—hold the claim, please

March 26, 2021

A percent not cut is a percent earned

March 19, 2021

Slaughter-ing pharma M&A?

March 12, 2021

The ARP of the deal: COVID relief package signed

March 5, 2021

No cost and—bonus—you get an experience that makes you unsure whether to laugh or cry

February 26, 2021

Our quiet days might be over, a new Becerra-iff in town

February 19, 2021

Judge tells hospitals to slow their roll with the 340B lawsuit

February 12, 2021

Blowing the lid off Medicaid rebates

February 5, 2021

Rules, rules, go away, come again another day


January 29, 2021

Anyone else picture the Mutombo finger wag? EO reverses previous policy and looks to expand coverage

January 22, 2021

Changing of the guard: new administration, new players

January 15, 2021

There’s always a critic: legal challenge filed against rebate rule

December 18, 2020

December 4, 2020

Health Policy Weekly

Better late than never? Regulatory sprint continues. 2021 PFS and OPPS final rules

November 23, 2020

Things That Come in 4s: Ninja Turtles, Suits in a Deck of Cards, Deadly Horsemen...and Final Rules on a Friday

November 20, 2020

Thankful for Rules, They Keep Things Interesting

November 13, 2020

Step 1, Gather the Key Ingredients: Transition COVID-19 Advisory Board Announced

November 6, 2020

SWEET! Impact of Making Insulin “Preventive” for Diabetes

October 16, 2020

340B: I Wish I Knew How to Quit You

October 30, 2020

Are Their True Colors Beautiful Like a Rainbow? Plan Transparency Final Rule Released

October 23, 2020

This, Too, Shall Pass: Election Politics and 2021 Scenario Planning

October 9, 2020

It’s Not Always About You, ACA: The Supreme Court Looks at PBMs

October 2, 2020

Send Us Your Tim Hortons, Your Molson, Your Barenaked Ladies, and Some Statins. Please and Thank You.

September 25, 2020

Urine It to Win It: Advancing Kidney Health

September 18, 2020

That’s So 2020: a Price-Control Order From a Republican President

September 11, 2020

IPPS Finally Here. CMS Finalizes MS-DRG for CAR-T Therapy

August 21, 2020

P Is for Progress: Kidney Health Initiative Update

August 14, 2020

Examining Kamala Harris’ Position on Healthcare

August 7, 2020

OPPS, I Did It Again. CMS Releases MPFS and OPPS Proposed Rules

July 31, 2020

If You Schedule a Meeting and No One Shows Up, Did It Ever Happen? Drug Pricing Executive Orders

July 17, 2020

The (COVID-19 Test) Price Is (Not) Right

July 10, 2020

Waiting in the Weeds for You: Democratic Task Force Agrees on Drug-Pricing Platform

June 26, 2020

I’ll Have the MRI for $1,500: Judge Upholds Hospital Price Transparency Rule

June 19, 2020

Finding Value in Unexpected Places: Happiness in a Late-Day Rule Drop

June 12, 2020

Photocopier Toner Companies Suffer Another Blow: Electronic Submissions of HCPCS Applications

June 5, 2020

WHO Cares. We All Should, Too

May 29, 2020

Millennium Falcon Not Included: Vaccines Hit Operation Warp Speed

May 15, 2020

Upsetting the Apple CAR-T: CMS Rules Offer Some Treats (and Some Bruises)

May 8, 2020

Is Your Homework Finished? Senate Dems Ask About National Strategic Plan

May 1, 2020

Call Me Maybe: Additional Information on Flexibility in Medicare

April 24, 2020

A Half Trillion Here, A Half Trillion There, and Pretty Soon You’re Talking Real Money

April 17, 2020

So You’re Telling Me There’s a Chance: Opening Up America Again

April 10, 2020

Hopping for a Cure. FDA Accelerates Approval of Possible Coronavirus Treatments

April 3, 2020

CMS Relaxing Regulations to Facilitate COVID-19 Care and Protect Healthcare Workers

March 27, 2020

John Maynard Keynes Would be Beaming

March 20, 2020

Federal Government Continues Actions to Control Spread of Coronavirus

March 6, 2020

Wanna Join Our Fans of Fauci Club? Federal Government Coronavirus Response

February 28, 2020

If Part B Ain’t Broke, Maybe Leave It Alone

February 21, 2020

Sweetening the Pie: Revised Definition for “Biologicals” Could Create Competition

February 14, 2020

Signed, Sealed, Delivered, I’m Yours: Administration’s 2021 Budget Plan

February 7, 2020

Was Congress Like This in 1917? SOTU Highlights Trenches

January 31, 2020

A Political Football: If It Looks Like a Block Grant and Acts Like a Block Grant…

January 24, 2020

Unequal to the Task (This Year): ACA Denied Fast Track

January 17, 2020

Can’t Triple Stamp a Double Stamp but Can Keep Challenging ACA

January 10, 2020

Start Me Up: Maryland’s New Prescription Drug Affordability Board Takes Shape

December 20, 2019

The Wait for the Importation Proposal Is Over: Hallelujah! Holy Cow! Where’s the Tylenol?

December 13, 2019

Like Sands Through an Hourglass…Legislative Efforts Unlikely To Go Anywhere

December 6, 2019

Quadfecta: Running Through Commissioners

November 22, 2019

Plucking Hospitals and Insurers: Transparency Requirements

November 15, 2019

BIO Says, Now Go Away or I Will Taunt You for a Second Time: CMS Releases 2020 Medicare Info

November 8, 2019

When Fri-YAY Becomes What-the-OPPS?

November 1, 2019

Bo Knows Sports. We Know Biosimilars.

October 25, 2019

Who’s on First, Health Care Is on Second, I Don’t Know Is on Third

October 18, 2019

Avoiding Prison Is Good: New Proposed Rules Offer Safe Harbor for Stark + Anti-Kickback

October 11, 2019

Avoiding Prison Is Good: New Proposed Rules Offer Safe Harbor for Stark + Anti-Kickback

October 4, 2019

Sometimes the Original Title Is Just More Descriptive: Trump Executive Order

September 27, 2019

Impeachment: At Least it Made Less News out of Drug Pricing in Congress?

September 13, 2019

Policy by FAQ: Why Bother With Formalities? Coupons Don’t Count Toward OOP

September 20, 2019

Like When You Watch the Olympics and Think, Yeah I Could Do That: House-Proposed Drug Bill Could Normalize Drug Pricing Proposals